NIG
SUPN icon

NFJ Investment Group’s Supernus Pharmaceuticals SUPN Stock Holding History

NFJ Investment Group’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.46M Hold
52,790
– – 0.08% 154
2026
Q1 		$2.73M Buy
+52,790
New +$2.69M 0.1% 136

Other funds holding SUPN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $9.33B AUM 56.1% 1-Year Est. Return

NFJ Investment Group's SUPN Position: Q2 2026 in Review

NFJ Investment Group held its Supernus Pharmaceuticals (SUPN) position steady in Q2 2026 at 52,790 shares worth $2.46M. The position accounts for 0.08% of the portfolio, ranked #154.

NFJ Investment Group first reported a position in SUPN in Q1 2026 and has held it in 2 quarters since. The position peaked at $2.73M in Q1 2026. 335 funds tracked by Wall St. Rank hold SUPN as of Q2 2026.

  • NFJ Investment Group held 52,790 shares of Supernus Pharmaceuticals worth $2.46M as of Q2 2026.
  • NFJ Investment Group left its Supernus Pharmaceuticals share count unchanged in Q2 2026.
  • Supernus Pharmaceuticals made up 0.08% of NFJ Investment Group's portfolio in Q2 2026, its #154 holding.
  • NFJ Investment Group first reported a position in Supernus Pharmaceuticals in Q1 2026 and has held it in 2 quarters since.
  • NFJ Investment Group's Supernus Pharmaceuticals position peaked at $2.73M in Q1 2026.
  • 335 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q2 2026.

Based on NFJ Investment Group's 13F filing for Q2 2026, filed 11 Aug 2026.